TCR2 THERAPEUTICS INC. Quarterly Other Liabilities, Noncurrent in USD from Q4 2018 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Tcr2 Therapeutics Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2018 to Q4 2022.
  • Tcr2 Therapeutics Inc. Other Liabilities, Noncurrent for the quarter ending December 31, 2022 was $0.000, a 100% decline year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $0 -$293K -100% Dec 31, 2022 10-K 2023-03-23
Q3 2022 $0 -$299K -100% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $0 -$257K -100% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $313K -$579K -64.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $293K -$514K -63.7% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $299K -$336K -52.9% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $257K -$352K -57.8% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $892K +$309K +53% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $807K +$261K +47.8% Dec 31, 2020 10-K 2022-03-22
Q3 2020 $635K +$161K +34% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $609K +$145K +31.3% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $583K +$128K +28.1% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $546K +$112K +25.8% Dec 31, 2019 10-K 2021-03-16
Q3 2019 $474K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $464K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $455K Mar 31, 2019 10-Q 2019-05-13
Q4 2018 $434K Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.